Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC). [electronic resource] by
- Fury, M G
- Sherman, E J
- Rao, S S
- Wolden, S
- Smith-Marrone, S
- Mueller, B
- Ng, K K
- Dutta, P R
- Gelblum, D Y
- Lee, J L
- Shen, R
- Kurz, S
- Katabi, N
- Haque, S
- Lee, N Y
- Pfister, D G
Producer: 20141118
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|